 PONTE VEDRA, Fla., Aug. 24, 2022 GLOBE NEWSWIRE -- Treace Medical Concepts, Inc. Treace NasdaqGS: TMCI, a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus commonly known as bunions through its Lapiplasty 3D Bunion CorrectionTM procedure, today announced that John T. Treace, Chief Executive Officer, and Mark L. Hair, Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference on Tuesday, September 13, 2022, beginning at approximately 8:35 am ET. 